CHOLESTYRAMINE, CLOFIBRATE AND NICOTINIC-ACID AS SINGLE OR COMBINED TREATMENT OF TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA

被引:0
|
作者
ORO, L
OLSSON, AG
ROSSNER, S
CARLSON, LA
机构
[1] KAROLINSKA SJUKHUSET,LIPID CLIN,DEPT INTERN MED,STOCKHOLM,SWEDEN
[2] KAROLINSKA SJUKHUSET,KING GUSTAF V RES INST,STOCKHOLM,SWEDEN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:76 / 81
页数:6
相关论文
共 50 条
  • [41] LATHOSTEROL LEVEL IN PLASMA IS ELEVATED IN TYPE-III HYPERLIPOPROTEINEMIA, BUT NOT IN NON-TYPE-III SUBJECTS WITH APOLIPOPROTEIN E2/2 PHENOTYPE, NOR IN TYPE-IIA OR TYPE-IIB HYPERLIPOPROTEINEMIA
    KEMPEN, HJM
    LEUVEN, JAG
    VANDERVOORT, HA
    DEKNIJFF, P
    HAVEKES, L
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (03): : 231 - 235
  • [42] CHARACTERIZATION OF RECOMBINANT VONWILLEBRAND-FACTOR CORRESPONDING TO MUTATIONS IN TYPE-IIA AND TYPE-IIB VONWILLEBRAND DISEASE
    RIBBA, AS
    VOORBERG, J
    MEYER, D
    PANNEKOEK, H
    PIETU, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (32) : 23209 - 23215
  • [43] EFFECTS OF CLOFIBRATE, NICOTINIC-ACID AND DIET ON PROPERTIES OF PLASMA LIPOPROTEINS IN A SUBJECT WITH TYPE-III HYPERLIPOPROTEINEMIA
    PATSCH, JR
    YESHURUN, D
    JACKSON, RL
    GOTTO, AM
    AMERICAN JOURNAL OF MEDICINE, 1977, 63 (06): : 1001 - 1009
  • [44] INSULIN RESISTANCE, GLUCOSE-INTOLERANCE AND HYPERINSULINEMIA IN HYPERCHOLESTEROLEMIA - DIFFERENCES BETWEEN TYPE-IIA AND TYPE-IIB
    SHEU, WHH
    CHEN, YDI
    SHIEH, SM
    SHEN, DDC
    FUH, MMT
    JENG, CY
    REAVEN, GM
    CLINICAL RESEARCH, 1993, 41 (01): : A11 - A11
  • [45] REDUCTION OF MYOCARDIAL REINFARCTION BY COMBINED TREATMENT WITH CLOFIBRATE AND NICOTINIC-ACID
    CARLSON, LA
    DANIELSON, M
    EKBERG, I
    KLINTEMAR, B
    ROSENHAMER, G
    ATHEROSCLEROSIS, 1977, 28 (01) : 81 - 86
  • [46] EFFECT OF COLESTIPOL AND CLOFIBRATE, SINGLY AND IN COMBINATION, ON PLASMA-LIPID AND LIPOPROTEINS IN TYPE-IIB HYPERLIPOPROTEINEMIA
    HUNNINGHAKE, DB
    BELL, C
    OLSON, L
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (06): : 610 - 615
  • [47] COMPARISON OF NA+ CURRENTS FROM TYPE-IIA AND TYPE-IIB HUMAN INTERCOSTAL MUSCLE-FIBERS
    RUFF, RL
    WHITTLESEY, D
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01): : C171 - C177
  • [48] LIPID-LOWERING EFFECT OF THE NEW DRUGS ENICLOBRATE AND BECLOBRATE IN PATIENTS WITH HYPERLIPIDEMIA TYPE-IIA AND TYPE-IIB
    NAJEMNIK, C
    LAGEDER, H
    REGAL, H
    IRSIGLER, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-2 (12): : 2168 - 2169
  • [49] ACTIVITY OF BINIFIBRATE (WAC 104-BINIWAS) IN PATIENTS WITH TYPE-IIA, TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIAS
    DALMAU, M
    MONASTERIO, J
    NOGUES, R
    PICO, M
    BRUSEGHINI, L
    DIEZ, S
    FREIXES, J
    ANDREOLI, R
    JOURNAL DE PHARMACOLOGIE, 1983, 14 (04) : 708 - 708
  • [50] LACTATE-DEHYDROGENASE ISOZYMES IN TYPE-I, TYPE-IIA AND TYPE-IIB FIBERS OF RABBIT SKELETAL-MUSCLES
    LEBERER, E
    PETTE, D
    HISTOCHEMISTRY, 1984, 80 (03) : 295 - 298